Drug Trial Radar · NCT05397678
Trial to Compare BCG-Bulgaria and BCG-Denmark
Last checked: Nov 19, 2026Latest source record: Jan 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
15,000
Planned (sponsor's estimate)
Start
Oct 21, 2022
Primary completion
Jul 2024
Study completion Oct 2024
Sponsor
- Lead sponsor
- Bandim Health ProjectAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Southern Denmark
- First posted
- May 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (care provider, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 0 days, up to 1 year
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The trial will be a two-year outcome assessor-blinded RCT at the maternity ward of Hospital Simão Mendes (HNSM) in urban Bissau, Guinea-Bissau to compare vaccination with Bacillus Calmette-Guérin (BCG) Danish strain (AJ Vaccines, Copenhagen 1331 strain) versus BCG-Bulgaria (BB-NCIPD, BCG-SL 222 Sofia strain) 1:1 in 15,000 infants with respect to mortality, morbidity and case-fatality rate during hospital admission. The trial will also examine the association between BCG strains and BCG skin reaction kinetics and characteristics. As a secondary aim, this large study will be used to further evaluate the role of maternal BCG immune priming for overall health, since there are indications that the maternal BCG scar status influences offspring health outcomes.
Conditions
- Death; Neonatal
- Death, Infant
- Morbidity;Newborn
- Morbidity;Infant
- Non-specific Effects of Vaccines
Interventions
BCG-DenmarkBiological
AJ vaccines, Copenhagen 1331 strain
BCG-BulgariaBiological
BB-NCIPD Ltd., BCG-SL 222 Sofia strain
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause mortality riskTime frame: Six weeks of age
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bandim Health Project
Bissau, Guinea-Bissau · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.